Advanced non-small cell lung cancer
Conditions
Interventions
Case series:CalliSpheres @ carrier drug microsphere
Sponsors
Yongchuan Hospital Affiliated to Chongqing Medical University
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) with definite pathological diagnosis, there are 1 or more measurable lesions according to the mRECIST standard; (2) Aged 35-80 years old; (3) ECOG PS score 0-2, and the expected survival >3 months; (4) the gene test was wild-type and could not tolerate or reject standard chemoradiotherapy; (5) on the basis of the international union of cancer (UICC) TNM staging standards are set by the 2002 patients with stage III-IVa; (6) without interventional therapy, radiotherapy, chemotherapy and molecular targeted therapy within one month; Sign written informed consent.
Exclusion criteria
Exclusion criteria: (1) the presence of metastatic lesions at sites other than the lung; (2) renal dysfunction (urea nitrogen >430.0 mg/dL or blood creatinine >42.0 mg/dL); (3) uncontrollable hypertension, diabetes, cardiovascular disease with obvious symptoms, and large amount of pleural effusion; (4) loss of follow-up, failure of interventional embolization or death of non-research related factors during the study; (5) Other researchers determined that participants were unfit to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mRECIST; | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse Reation; | — |
Countries
China
Contacts
Public ContactYang Jianhua
Yongchuan Hospital Affiliated to Chongqing Medical University
Outcome results
None listed